Drug intelligence / Profile preview

Yiguanjian granules

Development stage
Unknown
Lead developer
China Shenwei Pharmaceutical Group
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Yiguanjian granules (一贯煎颗粒) are a modern granule formulation of Yiguanjian (Linking Decoction), a classic Traditional Chinese Medicine (TCM) formula first recorded in the Qing Dynasty medical text *Yi Fang Jie Du* (医方絜度). The formula is composed of six key botanical ingredients: Rehmannia root (*Rehmannia glutinosa*), Lycium fruit (*Lycium barbarum*), Glehnia root (*Glehnia littoralis*), Ophiopogon tuber (*Ophiopogon japonicus*), Dong Quai root (*Angelica sinensis*), and Melia fruit (*Melia toosendan*). It is approved in China as a Class 3.1 new Chinese medicine (derived from ancient classical prescriptions) for the treatment of Liver yin deficiency and qi stagnation syndrome, which clinically manifests as chest and hypochondriac pain, acid reflux, bitter taste in the mouth, dry throat, and emotional tension. It is also widely used and evaluated for chronic hepatitis, chronic gastritis, gastric and duodenal ulcers, intercostal neuralgia, neurosis, and liver cirrhosis. Multiple pharmaceutical companies in China, including Shineway Pharmaceutical, Jilin Aodong Taonan Pharmaceutical, Shanghai Kaibao Pharmaceutical, Jiangsu Kanion Pharmaceutical, and CR Sanjiu, have received regulatory approvals to manufacture and market their respective Yiguanjian granule products.

Brand names
Linking Decoction
Other names
Linking DecoctionYi Guan JianYGJYiguanjianYiguanjian decoction一贯煎一贯煎颗粒

Beyond the preview

Go deeper on Yiguanjian granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yiguanjian granules.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call